Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells

European Journal of Cell Biology

Volumn 89, Issue 11, 2010, Pages 843-852

  Castro Sanchez, Luis ^a   Soto Guzman, Adriana ^a   Navarro Tito, Napoleon ^a   Martinez Orozco, Raul ^a   Salazar, Eduardo Perez ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Breast cancer; CD9; DDR1; Type IV Collagen

Indexed keywords

ANTIBODY; CD9 ANTIGEN; CLATHRIN; COLLAGEN TYPE 4; DISCOIDIN DOMAIN RECEPTOR 1; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; TETRASPANIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTIGENS, CD; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CLATHRIN-COATED VESICLES; COLLAGEN TYPE IV; ENDOSOMES; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE GLYCOPROTEINS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 77956619768     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2010.07.004     Document Type: Article

References (70)

1. Alves F., Vogel W., Mossie K., Millauer B., Hofler H., Ullrich A. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene 1995, 10:609-618.
2. Aumailley M., Gayraud B. Structure and biological activity of the extracellular matrix. J. Mol. Med. 1998, 76:253-265.
3. Barker K.T., Martindale J.E., Mitchell P.J., Kamalati T., Page M.J., Phippard D.J., Dale T.C., Gusterson B.A., Crompton M.R. Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours. Oncogene 1995, 10:569-575.
4. Baudoux B., Castanares-Zapatero D., Leclercq-Smekens M., Berna N., Poumay Y. The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur. J. Cell Biol. 2000, 79:41-51.
5. Benmerah A., Lamaze C. Clathrin-coated pits: vive la difference?. Traffic 2007, 8:970-982.
6. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J. Cell Sci. 2001, 114:4143-4151.
7. Berditchevski F., Odintsova E. Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J. Cell Biol. 1999, 146:477-492.
8. Berditchevski F., Odintsova E. Tetraspanins as regulators of protein trafficking. Traffic 2007, 8:89-96.
9. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 1981, 256:1604-1607.
10. Boucheix C., Duc G.H., Jasmin C., Rubinstein E. Tetraspanins and malignancy. Expert Rev. Mol. Med. 2001, 2001:1-17.
11. Boucheix C., Rubinstein E. Tetraspanins. Cell Mol. Life. Sci 2001, 58:1189-1205.
12. Boudreau N., Sympson C.J., Werb Z., Bissell M.J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995, 267:891-893.
13. Cajot J.F., Sordat I., Silvestre T., Sordat B. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res. 1997, 57:2593-2597.
14. Charrin S., le Naour F., Silvie O., Milhiet P.E., Boucheix C., Rubinstein E. Lateral organization of membrane proteins: tetraspanins spin their web. Biochem. J. 2009, 420:133-154.
15. Deissler H., Kuhn E.M., Lang G.E., Deissler H. Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Int. J. Mol. Med. 2007, 20:643-652.
16. Espenel C., Margeat E., Dosset P., Arduise C., Le Grimellec C., Royer C.A., Boucheix C., Rubinstein E., Milhiet P.E. Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web. J. Cell Biol. 2008, 182:765-776.
17. Friedrichson T., Kurzchalia T.V. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 1998, 394:802-805.
18. Goschnick M.W., Jackson D.E. Tetraspanins-structural and signalling scaffolds that regulate platelet function. Mini Rev. Med. Chem. 2007, 7:1248-1254.
19. Grant B.D., Donaldson J.G. Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 2009, 10:597-608.
20. Gunwar S., Ballester F., Noelken M.E., Sado Y., Ninomiya Y., Hudson B.G. Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J. Biol. Chem 1998, 273:8767-8775.
21. Hansen C., Greengard P., Nairn A.C., Andersson T., Vogel W.F. Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Exp. Cell Res. 2006, 312:4011-4018.
22. Hemler M.E. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 2003, 19:397-422.
23. Hemler M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 2005, 6:801-811.
24. Hemler M.E. Targeting of tetraspanin proteins--potential benefits and strategies. Nat. Rev. Drug Discov. 2008, 7:747-758.
25. Hemler M.E., Mannion B.A., Berditchevski F. Association of TM4SF proteins with integrins: relevance to cancer. Biochim. Biophys. Acta 1996, 1287:67-71.
26. Hou G., Vogel W.F., Bendeck M.P. Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circ. Res. 2002, 90:1147-1149.
27. Ivanov A.I. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?. Methods Mol. Biol. 2008, 440:15-33.
28. Jacobson K., Mouritsen O.G., Anderson R.G. Lipid rafts: at a crossroad between cell biology and physics. Nat. Cell Biol. 2007, 9:7-14.
29. Johnson J.D., Edman J.C., Rutter W.J. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10891.
30. Jones M.C., Caswell P.T., Norman J.C. Endocytic recycling pathways: emerging regulators of cell migration. Curr. Opin. Cell Biol. 2006, 18:549-557.
31. Kamohara H., Yamashiro S., Galligan C., Yoshimura T. Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. FASEB J. 2001, 15:2724-2726.
32. Kotha J., Longhurst C., Appling W., Jennings L.K. Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway. Exp. Cell Res. 2008, 314:1811-1822.
33. Laval S., Butler R., Shelling A.N., Hanby A.M., Poulsom R., Ganesan T.S. Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth Differ. 1994, 5:1173-1183.
34. Lazo P.A. Functional implications of tetraspanin proteins in cancer biology. Cancer Sci. 2007, 98:1666-1677.
35. Levy S., Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 2005, 5:136-148.
36. Liu L., He B., Liu W.M., Zhou D., Cox J.V., Zhang X.A. Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J. Biol. Chem. 2007, 282:31631-31642.
37. Maecker H.T., Todd S.C., Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J. 1997, 11:428-442.
38. Maxfield F.R., McGraw T.E. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 2004, 5:121-132.
39. McClay D.R., Ettensohn C.A. Cell adhesion in morphogenesis. Annu. Rev. Cell Biol. 1987, 3:319-345.
40. McDonald J.A. Extracellular matrix assembly. Annu. Rev. Cell Biol. 1988, 4:183-207.
41. Miles A.J., Skubitz A.P., Furcht L.T., Fields G.B. Promotion of cell adhesion by single-stranded and triple-helical peptide models of basement membrane collagen alpha 1(IV)531-543. Evidence for conformationally dependent and conformationally independent type IV collagen cell adhesion sites. J. Biol. Chem. 1994, 269:30939-30945.
42. Min G., Wang H., Sun T.T., Kong X.P. Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution. J. Cell Biol. 2006, 173:975-983.
43. Miyado K., Yamada G., Yamada S., Hasuwa H., Nakamura Y., Ryu F., Suzuki K., Kosai K., Inoue K., Ogura A., Okabe M., Mekada E. Requirement of CD9 on the egg plasma membrane for fertilization. Science 2000, 287:321-324.
44. Miyake M., Inufusa H., Adachi M., Ishida H., Hashida H., Tokuhara T., Kakehi Y. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery. Oncogene 2000, 19:5221-5226.
45. Miyake M., Koyama M., Seno M., Ikeyama S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med. 1991, 174:1347-1354.
46. Munoz M.L., Calderon J., Rojkind M. The collagenase of Entamoeba histolytica. J. Exp. Med. 1982, 155:42-51.
47. Murayama Y., Shinomura Y., Oritani K., Miyagawa J., Yoshida H., Nishida M., Katsube F., Shiraga M., Miyazaki T., Nakamoto T., Tsutsui S., Tamura S., Higashiyama S., Shimomura I., Hayashi N. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J. Cell Physiol. 2008, 216:135-143.
48. Muschler J., Lochter A., Roskelley C.D., Yurchenco P., Bissell M.J. Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 1999, 10:2817-2828.
49. Nabi I.R. The polarization of the motile cell. J. Cell Sci. 1999, 112(Pt 12):1803-1811.
50. Nydegger S., Khurana S., Krementsov D.N., Foti M., Thali M. Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J. Cell Biol. 2006, 173:795-807.
51. Ono M., Handa K., Withers D.A., Hakomori S. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res. 1999, 59:2335-2339.
52. Park H.S., Kim K.R., Lee H.J., Choi H.N., Kim D.K., Kim B.T., Moon W.S. Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase. Oncol. Rep. 2007, 18:1435-1441.
53. Ram R., Lorente G., Nikolich K., Urfer R., Foehr E., Nagavarapu U. Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. J. Neurooncol. 2006, 76:239-248.
54. Rappoport J.Z., Simon S.M., Benmerah A. Understanding living clathrin-coated pits. Traffic 2004, 5:327-337.
55. Santoro S.A., Cunningham L.W. Platelet-collagen adhesion. Methods Enzymol. 1982, 82(Pt A):509-513.
56. Sauer G., Windisch J., Kurzeder C., Heilmann V., Kreienberg R., Deissler H. Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion. Clin. Cancer Res. 2003, 9:6426-6431.
57. Scherberich A., Giannone G., Perennou E., Takeda K., Boucheix C., Rubinstein E., Lanza F., Beretz A. FAK-mediated inhibition of vascular smooth muscle cell migration by the tetraspanin CD9. Thromb. Haemost. 2002, 87:1043-1050.
58. Scherberich A., Moog S., Haan-Archipoff G., Azorsa D.O., Lanza F., Beretz A. Tetraspanin CD9 is associated with very late-acting integrins in human vascular smooth muscle cells and modulates collagen matrix reorganization. Arterioscler. Thromb. Vasc. Biol. 1998, 18:1691-1697.
59. Shi W., Fan H., Shum L., Derynck R. The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J. Cell Biol. 2000, 148:591-602.
60. Shrivastava A., Radziejewski C., Campbell E., Kovac L., McGlynn M., Ryan T.E., Davis S., Goldfarb M.P., Glass D.J., Lemke G., Yancopoulos G.D. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell 1997, 1:25-34.
61. Stuart A.D., Brown T.D. Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes. J. Virol. 2006, 80:7500-7509.
62. Timpl R., Oberbaumer I., von der Mark H., Bode W., Wick G., Weber S., Engel J. Structure and biology of the globular domain of basement membrane type IV collagen. Ann. N.Y. Acad. Sci. 1985, 460:58-72.
63. Vogel W. Discoidin domain receptors: structural relations and functional implications. FASEB J. 1999, 13(Suppl.):S77-s82.
64. Vogel W., Gish G.D., Alves F., Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1997, 1:13-23.
65. Vogel W.F., Abdulhussein R., Ford C.E. Sensing extracellular matrix: an update on discoidin domain receptor function. Cell Signal. 2006, 18:1108-1116.
66. Vogel W.F., Aszodi A., Alves F., Pawson T. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol. Cell Biol. 2001, 21:2906-2917.
67. Wang C.Z., Hsu Y.M., Tang M.J. Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel. J. Cell Physiol. 2005, 203:295-304.
68. Weaver V.M., Lelievre S., Lakins J.N., Chrenek M.A., Jones J.C., Giancotti F., Werb Z., Bissell M.J. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002, 2:205-216.
69. Wisdom B.J., Gunwar S., Hudson M.D., Noelken M.E., Hudson B.G. Type IV collagen of Engelbreth-Holm-Swarm tumor matrix: identification of constituent chains. Connect. Tissue Res. 1992, 27:225-234.
70. Yoshinaga I.G., Vink J., Dekker S.K., Mihm M.C., Byers H.R. Role of alpha 3 beta 1 and alpha 2 beta 1 integrins in melanoma cell migration. Melanoma Res. 1993, 3:435-441.